ACE Inhibitors News and Research

RSS
ACE inhibitors act to reduce hypertension by interfering with the conversion of angiotensin I to artery-constricting angiotensin II. Blocking the production of angiotensin II results in arterial vasodilation and an accompanying reduction in blood pressure. ACE inhibitors currently are recommended as first-line therapy for hypertension in certain patient populations, because of their safety and efficacy.
Common hypertension drugs do not increase risk of severe, fatal COVID-19 infection

Common hypertension drugs do not increase risk of severe, fatal COVID-19 infection

Novel blood test for heart failure could lead to new diagnostics for COVID-19 patients

Novel blood test for heart failure could lead to new diagnostics for COVID-19 patients

Obesity and metabolic syndrome increase risk for severe influenza, COVID-19

Obesity and metabolic syndrome increase risk for severe influenza, COVID-19

Study: Amount of SARS-Cov-2 receptor is increased in patients with pre-existing cardiac conditions

Study: Amount of SARS-Cov-2 receptor is increased in patients with pre-existing cardiac conditions

UTHealth physicians investigate blood pressure drug's effect on improving COVID-19 outcomes

UTHealth physicians investigate blood pressure drug's effect on improving COVID-19 outcomes

Study: Hypertension medications can also reduce risk of colorectal cancer

Study: Hypertension medications can also reduce risk of colorectal cancer

ACE inhibition in kidney could influence pathogenesis of SARS-CoV-2

ACE inhibition in kidney could influence pathogenesis of SARS-CoV-2

Statin therapy linked to lower death rate in hospitalized patients with COVID-19

Statin therapy linked to lower death rate in hospitalized patients with COVID-19

Transgenic rice containing anti-hypertensive peptides lowers blood pressure in hypertensive rats

Transgenic rice containing anti-hypertensive peptides lowers blood pressure in hypertensive rats

COVID-19 and blood group in aortic valve replacement

COVID-19 and blood group in aortic valve replacement

RAAS inhibitors are safe to use in COVID-19 patients, study shows

RAAS inhibitors are safe to use in COVID-19 patients, study shows

Research looks at COVID-19 in cancer patients

Research looks at COVID-19 in cancer patients

ACE inhibitors should not be discontinued over fears about COVID-19, say researchers

ACE inhibitors should not be discontinued over fears about COVID-19, say researchers

High blood pressure drugs found to be safe for COVID-19 patients

High blood pressure drugs found to be safe for COVID-19 patients

New clinical trial to assess whether hypertension drug may reduce COVID-19 severity

New clinical trial to assess whether hypertension drug may reduce COVID-19 severity

Radboudumc researchers find essential mechanism in the disease process of COVID-19

Radboudumc researchers find essential mechanism in the disease process of COVID-19

ACE inhibitors appear to be safe and beneficial for COVID-19, say researchers

ACE inhibitors appear to be safe and beneficial for COVID-19, say researchers

Study shows why people with certain heart diseases may be more susceptible to COVID-19

Study shows why people with certain heart diseases may be more susceptible to COVID-19

RAS inhibitors and COVID-19 severity in hypertensive patients

RAS inhibitors and COVID-19 severity in hypertensive patients

Meis1 protein plays key role in stopping cell division in the heart

Meis1 protein plays key role in stopping cell division in the heart